Literature DB >> 15690081

The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B cell lymphopoiesis.

Kezhong Zhang1, Hetty N Wong, Benbo Song, Corey N Miller, Donalyn Scheuner, Randal J Kaufman.   

Abstract

B lymphocyte differentiation is coordinated with the induction of high-level Ig secretion and expansion of the secretory pathway. Upon accumulation of unfolded proteins in the lumen of the ER, cells activate an intracellular signaling pathway termed the unfolded protein response (UPR). Two major proximal sensors of the UPR are inositol-requiring enzyme 1alpha (IRE1alpha), an ER transmembrane protein kinase/endoribonuclease, and ER-resident eukaryotic translation initiation factor 2alpha (eIF2alpha) kinase (PERK). To elucidate whether the UPR plays an important role in lymphopoiesis, we carried out reconstitution of recombinase-activating gene 2-deficient (rag2-/-) mice with hematopoietic cells defective in either IRE1alpha- or PERK-mediated signaling. IRE1alpha-deficient (ire1alpha-/-) HSCs can proliferate and give rise to pro-B cells that home to bone marrow. However, IRE1alpha, but not its catalytic activities, is required for Ig gene rearrangement and production of B cell receptors (BCRs). Analysis of rag2-/- mice transplanted with IRE1alpha trans-dominant-negative bone marrow cells demonstrated an additional requirement for IRE1alpha in B lymphopoiesis: both the IRE1alpha kinase and RNase catalytic activities are required to splice the mRNA encoding X-box-binding protein 1 (XBP1) for terminal differentiation of mature B cells into antibody-secreting plasma cells. Furthermore, UPR-mediated translational control through eIF2alpha phosphorylation is not required for B lymphocyte maturation and/or plasma cell differentiation. These results suggest specific requirements of the IRE1alpha-mediated UPR subpathway in the early and late stages of B lymphopoiesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15690081      PMCID: PMC546421          DOI: 10.1172/JCI21848

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  70 in total

Review 1.  Transcriptional regulation of early B-lymphocyte differentiation.

Authors:  M O'Riordan; R Grosschedl
Journal:  Immunol Rev       Date:  2000-06       Impact factor: 12.988

2.  Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development.

Authors:  X Shen; R E Ellis; K Lee; C Y Liu; K Yang; A Solomon; H Yoshida; R Morimoto; D M Kurnit; K Mori; R J Kaufman
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

Review 3.  Plasma cells: finding new light at the end of B cell development.

Authors:  K L Calame
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

4.  Translational control is required for the unfolded protein response and in vivo glucose homeostasis.

Authors:  D Scheuner; B Song; E McEwen; C Liu; R Laybutt; P Gillespie; T Saunders; S Bonner-Weir; R J Kaufman
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

5.  Plasma cell differentiation requires the transcription factor XBP-1.

Authors:  A M Reimold; N N Iwakoshi; J Manis; P Vallabhajosyula; E Szomolanyi-Tsuda; E M Gravallese; D Friend; M J Grusby; F Alt; L H Glimcher
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

6.  Cultivation of aorta-gonad-mesonephros-derived hematopoietic stem cells in the fetal liver microenvironment amplifies long-term repopulating activity and enhances engraftment to the bone marrow.

Authors:  Masaki Takeuchi; Takashi Sekiguchi; Takahiko Hara; Taisei Kinoshita; Atsushi Miyajima
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

7.  IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA.

Authors:  Marcella Calfon; Huiqing Zeng; Fumihiko Urano; Jeffery H Till; Stevan R Hubbard; Heather P Harding; Scott G Clark; David Ron
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

8.  Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors.

Authors:  Carlos Lois; Elizabeth J Hong; Shirley Pease; Eric J Brown; David Baltimore
Journal:  Science       Date:  2002-01-10       Impact factor: 47.728

9.  Perk is essential for translational regulation and cell survival during the unfolded protein response.

Authors:  H P Harding; Y Zhang; A Bertolotti; H Zeng; D Ron
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

10.  XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.

Authors:  H Yoshida; T Matsui; A Yamamoto; T Okada; K Mori
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

View more
  157 in total

1.  The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule.

Authors:  Benedict C S Cross; Peter J Bond; Pawel G Sadowski; Babal Kant Jha; Jaroslav Zak; Jonathan M Goodman; Robert H Silverman; Thomas A Neubert; Ian R Baxendale; David Ron; Heather P Harding
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

2.  BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α.

Authors:  Diego A Rodriguez; Sebastian Zamorano; Fernanda Lisbona; Diego Rojas-Rivera; Hery Urra; Juan R Cubillos-Ruiz; Ricardo Armisen; Daniel R Henriquez; Emily H Cheng; Michal Letek; Tomas Vaisar; Thergiory Irrazabal; Christian Gonzalez-Billault; Anthony Letai; Felipe X Pimentel-Muiños; Guido Kroemer; Claudio Hetz
Journal:  EMBO J       Date:  2012-04-17       Impact factor: 11.598

3.  In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection.

Authors:  Liza M Cabuang; Tim Shaw; Margaret Littlejohn; Danni Colledge; Vitini Sozzi; Sally Soppe; Nadia Warner; Alex Thompson; Scott Preiss; Natasha Lam; Renae Walsh; Sharon R Lewin; Chloe L Thio; Gail Matthews; Stephen A Locarnini; Peter A Revill
Journal:  J Med Virol       Date:  2012-08       Impact factor: 2.327

4.  Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells.

Authors:  Rekha Rao; Srilatha Nalluri; Warren Fiskus; Andrew Savoie; Kathleen M Buckley; Kyungsoo Ha; Ramesh Balusu; Atul Joshi; Veena Coothankandaswamy; Jianguo Tao; Eduardo Sotomayor; Peter Atadja; Kapil N Bhalla
Journal:  Clin Cancer Res       Date:  2010-07-20       Impact factor: 12.531

5.  ER stress: Autophagy induction, inhibition and selection.

Authors:  Harun-Or Rashid; Raj Kumar Yadav; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Autophagy       Date:  2015-11-02       Impact factor: 16.016

Review 6.  Protein misfolding in the endoplasmic reticulum as a conduit to human disease.

Authors:  Miao Wang; Randal J Kaufman
Journal:  Nature       Date:  2016-01-21       Impact factor: 49.962

Review 7.  Endoplasmic reticulum stress: cell life and death decisions.

Authors:  Chunyan Xu; Beatrice Bailly-Maitre; John C Reed
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 8.  Unfolded protein response signaling and metabolic diseases.

Authors:  Jaemin Lee; Umut Ozcan
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

9.  Negative feedback by IRE1β optimizes mucin production in goblet cells.

Authors:  Akio Tsuru; Naoko Fujimoto; Satsuki Takahashi; Michiko Saito; Daisuke Nakamura; Megumi Iwano; Takao Iwawaki; Hiroshi Kadokura; David Ron; Kenji Kohno
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

10.  Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.

Authors:  Ping Hu; Zhang Han; Anthony D Couvillon; Randal J Kaufman; John H Exton
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.